EP 1064390 A1 20010103 - ENHANCED ANTI-TUMOR IMMUNITY
Title (en)
ENHANCED ANTI-TUMOR IMMUNITY
Title (de)
GESTEIGERTE ANTITUMORIMMUNITÄT
Title (fr)
IMMUNITE ANTITUMORALE AMELIOREE
Publication
Application
Priority
- US 9906037 W 19990319
- US 7890098 P 19980320
Abstract (en)
[origin: WO9947687A1] The present invention provides methods for inducing an antigen-specific immune response by administering allogeneic antigen-presenting cells to a subject. In another aspect, an effective amount of autologous antigen-presenting cells are co-administered to a subject.
IPC 1-7
IPC 8 full level
C12N 15/09 (2006.01); A61K 35/26 (2006.01); A61K 35/76 (2006.01); A61K 39/00 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); A61P 37/04 (2006.01)
CPC (source: EP US)
A61K 39/0011 (2013.01 - US); A61K 39/4615 (2023.05 - EP); A61K 39/4622 (2023.05 - EP); A61K 39/464499 (2023.05 - EP); A61P 35/00 (2018.01 - EP); A61P 37/04 (2018.01 - EP); A61K 2039/5156 (2013.01 - EP); A61K 2239/31 (2023.05 - EP); A61K 2239/38 (2023.05 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9947687 A1 19990923; AU 3102799 A 19991011; CA 2322660 A1 19990923; EP 1064390 A1 20010103; EP 1064390 A4 20020612; JP 2002506886 A 20020305
DOCDB simple family (application)
US 9906037 W 19990319; AU 3102799 A 19990319; CA 2322660 A 19990319; EP 99912714 A 19990319; JP 2000536870 A 19990319